Survivorship

Significant therapeutic advances for soft tissue sarcomas allow increasing numbers of patients - adult and pediatric - to achieve long term survival. However, the harsh cytotoxic therapies are responsible for adverse physical and psychosocial effects that require long-term follow-up care, specific to survivorship issues. In the adult and pediatric patient population, guidelines for care developed by experts in comprehensive survivorship clinics are evolving to assist the practitioner while on-line supports bring information directly to the survivors. J. Surg. Oncol. 2015 111:648-655.